MN to receive limited shipment of drug that reduces COVID-19 hospitalizations

The 2,400 doses are only for high risk children and adults.
Author:
Publish date:

Minnesota will soon receive 2,400 doses of a new drug that through clinical trials has shown the ability to keep COVID-19 patients from being hospitalized. 

The good news comes as Minnesota's healthcare systems are being flooded with people infected by the novel coronavirus. On Tuesday, the health department reported a record 1,669 COVID-19 patients in hospitals around the state, including 335 in intensive care. 

Commissioner Jan Malcom said in an MPR radio interview Monday that the booming case volume seen in the last week cold lead to the hospital totals doubling or tripling in a matter of weeks. 

The new drug, bamlanivimab, is being distributed nationwide by the U.S. Department of Health and Human Services. The antibody therapy is only for children and adults who are at high risk for severe disease, and it's critical that the drug is taken as soon as possible after a positive test and within 10 days of developing symptoms. 

Furthermore, it's only for people who aren't hospitalized but have mild to moderate COVID-19 symptoms – and a person cannot be receiving oxygen therapy. 

“To be able to use this treatment, people should get tested as soon as possible if they become ill and reach out to their health care provider quickly if they receive a positive test,” said Dr. Ruth Lynfield, state epidemiologist and medical director for the Minnesota Department of Health. “Supplies will be limited at this point, but this therapy provides an additional option to help limit the impacts of this serious disease.”

Sign up for our BREAKING NEWS newsletters

According to the health department, a recent study of bamlanivimab showed that high-risk patients with COVID-19 who took the drug wound up hospitalized or required a trip to an emergency room in just 3% of cases. That compares favorably to 10% of people involved in the study who received a placebo dose with no medicine in it being hospitalized or going to an ER. 

The health department defines high risk children and adults as someone "12 years of age and older with mild to moderate symptoms" and weigh 88 pounds or more. 

The most common side effects of bamlanivimab have been nausea, diarrhea, dizziness, headache, itching and vomiting, but only in 2-4% of people who took the drug. Allergic reactions are possible but uncommon, the health department said. 

Next Up

MasklessJudgesinWiscoyTownship

At Wiscoy Township's sole precinct, election judges ditched masks

Voter and Wiscoy resident Kaitlyn O'Connor took a photo of the judges after asking them to wear masks, she said

paisley park

Paisley Park to open pop-up shop at Mall of America

The new store is set to open on Black Friday.

blue-and-white-sorry-we-re-closed-wooden-signage-1171386

COVID-19: Here's what Gov. Walz, Republicans are proposing to help businesses

Once they come to an agreement, Walz will call a special session to pass the legislation.

Jacob Frey

Minneapolis Mayor Jacob Frey planning to run for reelection

Frey said in a radio interview that 2020 has been a "horrible" year.

Monello

Monello, P.S. Steak will switch to sandwiches, noodles during shutdown

The Minneapolis eateries are pivoting during the closure of dine-in service.

skiing

MN ski areas will be open – but with changes – during 4-week shutdown

Some ski areas have already reopened for the season, others plan to open Thanksgiving weekend.

thanksgiving turkey

Thanksgiving foods to avoid giving to pets

The Animal Humane Society has shared its advice on keeping pets safe this Thanksgiving.

best buy

Best Buy reports massive rise in online, in-store sales

People turned to Best Buy to buy computers, home theater and appliances during the pandemic.

police tape, crime scene

Driver dies after being shot, crashing into cars in Minneapolis

The incident happened around 1:25 a.m. Tuesday.

Related

coronavirus, nurse

MN surrounded by states reporting record COVID-19 hospitalizations

Of 16,656 people tested in Wisconsin in the latest reporting period, more than 3,100 were positive.

coronavirus, ICU

MDH stops publicizing current total COVID-19 hospitalizations

Total hospital capacity remains public, but how many COVID-19 patients are hospitalized is not.

coronavirus, SARS-CoV-2, covid-19

Here is Minnesota's COVID-19 update for Thursday, July 16

The positive cases are the result of 14,715 tests.

novel coronavirus, covid-19, sars-cov-2

Here is Minnesota's COVID-19 update for Wednesday, July 15

The number of patients in the hospital increased by 18 in the latest report.

coronavirus testing

Here is Minnesota's COVID-19 update for Wednesday, August 19

It's the most deaths reported in a single day since mid-June.